Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab
Clinical trial NCT00667329 · COMPLETED
Trial details
- NCT number
- NCT00667329
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-09
- Primary completion
- 2022-02-10
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.